Ciprofloxacin

Microbiology — Pharmacokinetics — Clinical Experience

  • Editors
  • H. C. Neu
  • D. S. Reeves
Book

Part of the Current Topics in Infectious Diseases and Clinical Microbiology book series (CTIDCM, volume 1)

Table of contents

  1. Front Matter
    Pages I-VII
    PDF

  2. Microbiology

    1. Front Matter
      Pages 1-1
      PDF

    2. Articles

      1. A Laboratory Assessment of Ciprofloxacin and Comparable Antimicrobial Agents
        L. Shrire, J. Saunders, R. Traynor, H. J. Kornhof
        Pages 3-7
      2. Comparative in Vitro Activity of Five Quinoline Derivatives and Five Other Antimicrobial Agents Used in Oral Therapy
        J. A. A. Hoogkamp-Korstanje
        Pages 8-13
      3. The In Vitro and In Vivo Activity of Ciprofloxacin
        H.-J. Zeiler, K. Grohe
        Pages 14-18
      4. The Activity of Ciprofloxacin and Other 4-Quinolones Against Chlamydia trachomatis and Mycoplasmas In Vitro
        G. L. Ridgway, G. Mumtaz, F. G. Gabriel, J. D. Oriel
        Pages 19-21
      5. Mutational Resistance to 4-Quinolone Antibacterial Agents
        J. T. Smith
        Pages 22-25
      6. Antibacterial Activity of Ciprofloxacin in Conventional Tests and in a Model of Bacterial Cystitis
        D. Greenwood, S. Baxter, A. Cowlishaw, A. Eley, G. J. Slater
        Pages 26-29

    3. Notes

      1. Comparison of the in Vitro Activity of Ciprofloxacin (Bay o 9867) and Norfloxacin Against Gastrointestinal Tract Pathogens
        M. Diez-Enciso, G. Mas-Jimenez, A. Velasco-Cerrudo, A. Gutierrez-Altes
        Pages 30-30
      2. In Vitro Activity of Ciprofloxacin, Azthreonam and Ceftazidime Against Serratia marcescens and Pseudomonas aeruginosa
        J. Righter
        Pages 31-32
      3. In Vitro Activity of Ciprofloxacin Against Bacteroides, Haemophilus influenzae and Branhamella catarrhalis
        B. Olsson-Liljequist
        Pages 33-34
      4. In Vitro Activity of Ciprofloxacin Against Brucella melitensis
        M. Gobernado, E. Cantón, M. Santos
        Pages 34-34
      5. In Vitro Activity of Ciprofloxacin Against Clinical Isolates of Chlamydia trachomatis
        H. Meier-Ewert, G. Weil, G. Millott
        Pages 35-35
      6. Susceptibility of Legionella spp. to Quinolone Derivatives and Related Organic Acids
        G. Ruckdeschel, W. Ehret, A. Ahl
        Pages 36-36
      7. In Vitro Activity of Ciprofloxacin and Norfloxacin Against Gardnerella vaginalis
        K. Machka
        Pages 37-37
      8. In Vitro Activity of Ciprofloxacin Against Group JK Corynebacteria
        K. Machka, H. Balg
        Pages 38-38

  3. Pharmacokinetics

    1. Front Matter
      Pages 39-39
      PDF

    2. Articles

      1. Pharmacokinetics of Ciprofloxacin in Healthy Volunteers after Oral and Intravenous Administration
        K. Borner, G. Höffken, H. Lode, P. Koeppe, C. Prinzing, P. Glatzel et al.
        Pages 41-48
      2. Pharmacokinetics of Ciprofloxacin after Intravenous and Increasing Oral Doses
        T. Bergan, S. B. Thorsteinsson, I. M. Kolstad, S. Johnsen
        Pages 49-54
      3. Single and Multiple Dose Pharmacokinetics of Ciprofloxacin
        U. Ullmann, W. Giebel, A. Dalhoff, P. Koeppe
        Pages 55-58

About this book

Keywords

Antibiotika Antibiotikum Bakterien Chemotherapie Ciprofloxacin Droge Infektion Infektionen Mikrobiologie Pharmakokinetik Pseudomonas Resistenz Therapeut Wachstum antimicrobial

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-663-01930-5
  • Copyright Information Springer Fachmedien Wiesbaden 1986
  • Publisher Name Vieweg+Teubner Verlag, Wiesbaden
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-663-01931-2
  • Online ISBN 978-3-663-01930-5
  • About this book
Industry Sectors
Chemical Manufacturing
Biotechnology
Consumer Packaged Goods
Pharma